Contributo scientifico, sviluppato generalmente su uno specifico argomento, che illustra risultati originali di una ricerca o presenta caratteristiche di review, cioè di discussione dello stato dell’arte o della letteratura entro un ambito scientifico definito. La rivista di pubblicazione deve presentare caratteristiche di scientificità. La tipologia non comprende editoriali, commenti brevi, repliche, abstract, errata, recensioni e prodotti similari, per i quali sono previste specifiche tipologie.
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study
2011 Barbui, T; Thiele, J; Passamonti, F; Rumi, E; Boveri, E; Ruggeri, M; Rodeghiero, F; D'Amore, Es; Randi, Ml; Bertozzi, I; Marino, F; Vannucchi, Am; Antonioli, E; Carrai, V; Gisslinger, H; Buxhofer-Ausch, V; Mullauer, L; Carobbio, A; Gianatti, A; Gangat, N; Hanson, Ca; Tefferi, A
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis
2012 Barbui, T; Thiele, J; Carobbio, A; Passamonti, F; Rumi, E; Randi, Ml; Bertozzi, I; Vannucchi, Am; Gisslinger, H; Gisslinger, B; Finazzi, G; Ruggeri, M; Rodeghiero, F; Rambaldi, A; Gangat, N; Tefferi, A
Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study
2020 Pozzi, A.; Gori, M.; Iorio, A.; Iacovoni, A.; Carobbio, A.; Cioffi, G.; De Maria, R.; Grosu, A.; Fontana, A.; Canova, P. A.; Calabrese, A.; Ferrari, P.; Parati, G.; Lorini, F. L.; Senni, M.; Gavazzi, A.
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients
2012 Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi-Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, Pe; Iacopino, P; Arcese, W; Scime, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, A
Leukocytosis and thrombosis in polycythemia vera: can clinical trials settle the debate?
2019 Barbui, T; Carobbio, A; Ferrari, A
Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial
2016 Brucato, A; Imazio, M; Gattorno, M; Lazaros, G; Maestroni, S; Carraro, M; Finetti, M; Cumetti, D; Carobbio, A; Ruperto, N; Marcolongo, R; Lorini, M; Rimini, A; Valenti, A; Erre, Gl; Sormani, Mp; Belli, R; Gaita, F; Martini, A
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma
2015 Massi, D; Simi, L; Sensi, E; Baroni, G; Xue, G; Scatena, C; Caldarella, A; Pinzani, P; Fontanini, G; Carobbio, A; Urso, C; Mandala, M
A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes
2009 Intermesoli, T; Delaini, F; Acerboni, S; Salmoiraghi, S; Spinelli, O; Guerini, V; Vannucchi, Am; Mappa, S; Rossi, G; Rossi, V; Di Bona, E; Paratore, S; Carobbio, A; Rambaldi, A; Barbui, T; Bassan, R
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with
2015 Barbui, T; Vannucchi, Am; Buxhofer-Ausch, V; De Stefano, V; Betti, S; Rambaldi, A; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Gisslinger, H; Finazzi, G; Carobbio, A; Thiele, J; Passamonti, F; Falcone, C; Tefferi, A
Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria
2010 Carobbio, A; Finazzi, G; Antonioli, E; Vannucchi, Am; Barosi, G; Ruggeri, M; Rodeghiero, F; Delaini, F; Rambaldi, A; Barbui, T
Essential thrombocythemia with high hemoglobin levels according to the revised WHO classification
2014 Barbui, T; Thiele, J; Kvasnicka, Hm; Carobbio, A; Vannucchi, Am; Tefferi, A
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases
2018 De Stefano, V; Rossi, E; Carobbio, A; Ghirardi, A; Betti, S; Finazzi, G; Vannucchi, Am; Barbui, T
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma
2011 Tarella, C; Passera, R; Magni, M; Benedetti, F; Rossi, A; Gueli, A; Patti, C; Parvis, G; Ciceri, F; Gallamini, A; Cortelazzo, S; Zoli, V; Corradini, P; Carobbio, A; Mule, A; Bosa, M; Barbui, A; Di Nicola, M; Sorio, M; Caracciolo, D; Gianni, Am; Rambaldi, A
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
2017 Lussana, F; Carobbio, A; Salmoiraghi, S; Guglielmelli, P; Vannucchi, Am; Bottazzi, B; Leone, R; Mantovani, A; Barbui, T; Rambaldi, A
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
2012 Finazzi, G; Carobbio, A; Thiele, J; Passamonti, F; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Vannucchi, Am; Antonioli, E; Gisslinger, H; Buxhofer-Ausch, V; Gangat, N; Rambaldi, A; Tefferi, A; Barbui, T
A lexicographic pricer for the fractional bin packing problem
2019 Coniglio, S.; D'Andreagiovanni, F.; Furini, F.
A fast robust optimization-based heuristic for the deployment of green virtual network functions
2017 Marotta, A; Zola, E; D'Andreagiovanni, F; Kassler, A
WDM Fiber Replacement Scheduling
2013 Bley, A; Karch, D; D'Andreagiovanni, F
Green Design of Wireless Local Area Networks by Multiband Robust Optimization
2018 D'Andreagiovanni, F; Garroppo, R G; Scutellà, M G
Towards the fast and robust optimal design of wireless body area networks
2015 D'Andreagiovanni, F; Nardin, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study | 1-gen-2011 | Barbui, T; Thiele, J; Passamonti, F; Rumi, E; Boveri, E; Ruggeri, M; Rodeghiero, F; D'Amore, Es; Randi, Ml; Bertozzi, I; Marino, F; Vannucchi, Am; Antonioli, E; Carrai, V; Gisslinger, H; Buxhofer-Ausch, V; Mullauer, L; Carobbio, A; Gianatti, A; Gangat, N; Hanson, Ca; Tefferi, A | |
| Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis | 1-gen-2012 | Barbui, T; Thiele, J; Carobbio, A; Passamonti, F; Rumi, E; Randi, Ml; Bertozzi, I; Vannucchi, Am; Gisslinger, H; Gisslinger, B; Finazzi, G; Ruggeri, M; Rodeghiero, F; Rambaldi, A; Gangat, N; Tefferi, A | |
| Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study | 1-gen-2020 | Pozzi, A.; Gori, M.; Iorio, A.; Iacovoni, A.; Carobbio, A.; Cioffi, G.; De Maria, R.; Grosu, A.; Fontana, A.; Canova, P. A.; Calabrese, A.; Ferrari, P.; Parati, G.; Lorini, F. L.; Senni, M.; Gavazzi, A. | |
| Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patients | 1-gen-2012 | Rambaldi, A; Bacigalupo, A; Fanin, R; Ciceri, F; Bonifazi, F; Falda, M; Lambertenghi-Deliliers, G; Benedetti, F; Bruno, B; Corradini, P; Alessandrino, Pe; Iacopino, P; Arcese, W; Scime, R; Raimondi, R; Sica, S; Castagna, L; Lamparelli, T; Oneto, R; Lombardini, L; Pollichieni, S; Algarotti, A; Carobbio, A; Sacchi, N; Bosi, A | |
| Leukocytosis and thrombosis in polycythemia vera: can clinical trials settle the debate? | 1-gen-2019 | Barbui, T; Carobbio, A; Ferrari, A | |
| Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial | 1-gen-2016 | Brucato, A; Imazio, M; Gattorno, M; Lazaros, G; Maestroni, S; Carraro, M; Finetti, M; Cumetti, D; Carobbio, A; Ruperto, N; Marcolongo, R; Lorini, M; Rimini, A; Valenti, A; Erre, Gl; Sormani, Mp; Belli, R; Gaita, F; Martini, A | |
| Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma | 1-gen-2015 | Massi, D; Simi, L; Sensi, E; Baroni, G; Xue, G; Scatena, C; Caldarella, A; Pinzani, P; Fontanini, G; Carobbio, A; Urso, C; Mandala, M | |
| A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes | 1-gen-2009 | Intermesoli, T; Delaini, F; Acerboni, S; Salmoiraghi, S; Spinelli, O; Guerini, V; Vannucchi, Am; Mappa, S; Rossi, G; Rossi, V; Di Bona, E; Paratore, S; Carobbio, A; Rambaldi, A; Barbui, T; Bassan, R | |
| Practice-relevant revision of IPSET-thrombosis based on 1019 patients with | 1-gen-2015 | Barbui, T; Vannucchi, Am; Buxhofer-Ausch, V; De Stefano, V; Betti, S; Rambaldi, A; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Gisslinger, H; Finazzi, G; Carobbio, A; Thiele, J; Passamonti, F; Falcone, C; Tefferi, A | |
| Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria | 1-gen-2010 | Carobbio, A; Finazzi, G; Antonioli, E; Vannucchi, Am; Barosi, G; Ruggeri, M; Rodeghiero, F; Delaini, F; Rambaldi, A; Barbui, T | |
| Essential thrombocythemia with high hemoglobin levels according to the revised WHO classification | 1-gen-2014 | Barbui, T; Thiele, J; Kvasnicka, Hm; Carobbio, A; Vannucchi, Am; Tefferi, A | |
| Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases | 1-gen-2018 | De Stefano, V; Rossi, E; Carobbio, A; Ghirardi, A; Betti, S; Finazzi, G; Vannucchi, Am; Barbui, T | |
| Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma | 1-gen-2011 | Tarella, C; Passera, R; Magni, M; Benedetti, F; Rossi, A; Gueli, A; Patti, C; Parvis, G; Ciceri, F; Gallamini, A; Cortelazzo, S; Zoli, V; Corradini, P; Carobbio, A; Mule, A; Bosa, M; Barbui, A; Di Nicola, M; Sorio, M; Caracciolo, D; Gianni, Am; Rambaldi, A | |
| Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera | 1-gen-2017 | Lussana, F; Carobbio, A; Salmoiraghi, S; Guglielmelli, P; Vannucchi, Am; Bottazzi, B; Leone, R; Mantovani, A; Barbui, T; Rambaldi, A | |
| Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria | 1-gen-2012 | Finazzi, G; Carobbio, A; Thiele, J; Passamonti, F; Rumi, E; Ruggeri, M; Rodeghiero, F; Randi, Ml; Bertozzi, I; Vannucchi, Am; Antonioli, E; Gisslinger, H; Buxhofer-Ausch, V; Gangat, N; Rambaldi, A; Tefferi, A; Barbui, T | |
| A lexicographic pricer for the fractional bin packing problem | 1-gen-2019 | Coniglio, S.; D'Andreagiovanni, F.; Furini, F. | |
| A fast robust optimization-based heuristic for the deployment of green virtual network functions | 1-gen-2017 | Marotta, A; Zola, E; D'Andreagiovanni, F; Kassler, A | |
| WDM Fiber Replacement Scheduling | 1-gen-2013 | Bley, A; Karch, D; D'Andreagiovanni, F | |
| Green Design of Wireless Local Area Networks by Multiband Robust Optimization | 1-gen-2018 | D'Andreagiovanni, F; Garroppo, R G; Scutellà, M G | |
| Towards the fast and robust optimal design of wireless body area networks | 1-gen-2015 | D'Andreagiovanni, F; Nardin, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA69851
- Atti di CONVEGNO1
- Contributo su VOLUME1
Data di pubblicazione
- 2020 - 202720192
- 2010 - 201923511
- 2000 - 200914315
- 1990 - 19998032
- 1980 - 19893149
- 1970 - 1979640
- 1966 - 196911
Editore
- Elsevier BV:PO Box 211, 1000 AE A...334
- American Institute of Physics:2 H...226
- Elsevier Science Limited:Oxford F...189
- Giuffre Editore Spa:via Busto Ars...101
- Societa Editrice il Mulino Spa:St...73
- Springer Verlag Germany:Tiergarte...71
- IEEE / Institute of Electrical an...70
- Academic Press Incorporated:6277 ...67
- American Chemical Society:1155 Si...63
- Edizioni Minerva Medica:Corso Bra...59
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS404
- EFSA JOURNAL380
- PLOS ONE315
- PHYSICAL REVIEW LETTERS309
- PHYSICAL REVIEW. B, CONDENSED MAT...294
- SCIENTIFIC REPORTS290
Serie
- EUROPEAN DISTANCE AND E-LEARNING ...1
Keyword
- Humans4564
- Female2681
- Male2251
- Middle Aged1673
- Adult1526
- Aged1328
- Italy767
- Treatment Outcome649
- COVID-19587
- 80 and over506
Lingua
- eng58327
- ita10772
- fre334
- spa299
- ger189
- por61
- rus24
- und23
- chi15
- pol6
Accesso al fulltext
- no fulltext29929
- open19773
- reserved18695
- partially open1440
- embargoed15
- mixed1